The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 350.00
Bid: 350.00
Ask: 355.00
Change: 10.00 (2.94%)
Spread: 5.00 (1.429%)
Open: 335.00
High: 350.00
Low: 335.00
Prev. Close: 340.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

6 Jul 2017 07:00

RNS Number : 2365K
Microgen PLC
06 July 2017
 

6 July 2017

 

MICROGEN plc ('Microgen' or 'Group')

 

TRADING UPDATE AND NOTICE OF RESULTS

 

 

Ahead of announcing Interim Results for the six months ended 30 June 2017 on 24 July 2017, Microgen (MCGN.L), a leading provider of business critical software and services, today issues the following update on trading for the financial year to date.

The Group has made excellent progress in the first half of 2017 resulting in a financial performance ahead of the Board's original expectations for the period whilst maintaining margins consistent with the prior year. The Group's two businesses are successfully executing their declared strategy with Aptitude Software delivering strong organic growth and Microgen Financial Systems successfully continuing on its transition towards a business focused on the Trust & Fund Administration ('T&FA') market.

A key highlight for the Group is the continued new business wins that have driven growth in Aptitude Software's recurring revenue base. Since 30 June 2016, the recurring revenue in Aptitude Software has increased 42% to £15.0 million as at 30 June 2017 (H1, 2016: £10.6 million and 31 December 2016: £12.6 million). There has also been exceptional growth in demand for Aptitude Software's implementation services in the first half of the year as a number of clients progress towards going live with the Aptitude Revenue Recognition Engine ('ARRE'). Upon completion of the half year the Board has reviewed the on-going demand for Aptitude Software's implementation services and, whilst clients' requirements continue to evolve, the Board is now confident that the exceptional level of demand experienced in the first six months of the year will continue throughout 2017, leading to a financial performance for the Group significantly ahead of the Board's expectations for the year. 

Opportunities for Aptitude's existing software and its new products provide the business with confidence for future years. Partners are becoming an increasingly important channel for new business, and as they provide a growing proportion of resources for new implementations, and as a number of the larger ARRE projects are completed, the exceptional level of demand for services experienced in 2017 is expected to moderate in 2018.

Microgen Financial Systems has maintained its focus on the T&FA market within the wealth management sector. The acquisition of Primacy Corporation in February 2017, a competitor in the T&FA market, represented the fifth acquisition since December 2014 and further strengthens the position of the business in this market. As a result of this focus T&FA revenues now represent approximately 60% of Microgen Financial Systems' H1 2017 revenue (H1, 2016: 51%), compared to 33% at the beginning of this transition in 2014.

 

Contacts

Ivan Martin, Chairman 020-7496-8100

Philip Wood, Chief Financial Officer

 

James Melville-Ross / Darius Alexander 020-3727-1000

FTI Consulting

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUUGMUPMGAA
Date   Source Headline
9th Mar 20189:06 amRNSTotal Voting Rights
7th Mar 20187:00 amRNSAudited Preliminary Results
21st Feb 20182:33 pmRNSDirector Declaration
19th Feb 20181:42 pmRNSHolding(s) in Company
12th Feb 20189:30 amRNSFWD fires starter gun on IFRS 17 implementation
1st Feb 20181:59 pmRNSTotal Voting Rights
18th Jan 20187:00 amRNSTrading Update and Notice of Results
27th Nov 20174:13 pmRNSDirector Declaration
18th Oct 201710:37 amRNSHolding(s) in Company
9th Oct 201712:42 pmRNSHolding(s) in Company
2nd Oct 201711:51 amRNSBlock Listing Return
2nd Oct 201711:49 amRNSTotal Voting Rights
25th Sep 20178:39 amRNSHolding(s) in Company
21st Sep 20178:30 amRNSHolding(s) in Company
18th Sep 201712:16 pmRNSHolding(s) in Company
14th Sep 20174:45 pmRNSHolding(s) in Company
13th Sep 201712:05 pmRNSHolding(s) in Company
12th Sep 20178:33 amRNSHolding(s) in Company
7th Sep 20178:00 amRNSHolding(s) in Company
31st Aug 20177:00 amRNSAcquisition of RevStream
18th Aug 20174:36 pmRNSHolding(s) in Company
11th Aug 201710:47 amRNSAward of Options
4th Aug 20179:50 amRNSHolding(s) in Company
25th Jul 20173:50 pmRNSHolding(s) in Company
24th Jul 20171:12 pmRNSHolding(s) in Company
24th Jul 20177:00 amRNSInterim Results
6th Jul 20177:00 amRNSTrading Update and Notice of Results
30th Jun 20172:11 pmRNSTotal Voting Rights
21st Jun 20173:06 pmRNSHolding(s) in Company
2nd Jun 20171:43 pmRNSTotal Voting Rights
1st Jun 20177:00 amRNSHolding(s) in Company
17th May 20177:00 amRNSDirector Declaration
17th May 20177:00 amRNSHolding(s) in Company
12th May 201712:08 pmRNSHolding(s) in Company
9th May 20177:00 amRNSHolding(s) in Company
24th Apr 201712:15 pmRNSResult of AGM
24th Apr 20177:00 amRNSAGM Trading update
11th Apr 20174:09 pmRNSHolding(s) in Company
3rd Apr 20177:00 amRNSBlock listing Interim Review
21st Mar 201712:51 pmRNSHolding(s) in Company
17th Mar 201711:22 amRNSHolding(s) in Company
16th Mar 20174:31 pmRNSDirector/PDMR Shareholding
14th Mar 20174:32 pmRNSHolding(s) in Company
9th Mar 20174:38 pmRNSHolding(s) in Company
8th Mar 20177:00 amRNSAudited Preliminary Results
28th Feb 20177:00 amRNSDirectorate Change
27th Feb 20177:00 amRNSAcquisition of Primacy Corporation
6th Feb 20173:39 pmRNSHolding(s) in Company
3rd Feb 20175:22 pmRNSHolding(s) in Company
1st Feb 20172:24 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.